Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 10
Submit an article Journal homepage
2,056
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Combination immune checkpoint blockade as an effective therapy for mesothelioma

Vanessa S. FearNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8363-6685View further author information
ORCID Icon,
Caitlin TilsedNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaORCID Iconhttp://orcid.org/0000-0002-9066-5182View further author information
ORCID Icon,
Jonathan CheeNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaORCID Iconhttp://orcid.org/0000-0002-7986-2708View further author information
ORCID Icon,
Catherine A. ForbesNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaView further author information
,
Thomas CaseyNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaView further author information
,
Jessica N. SolinNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, AustraliaView further author information
,
Sally M. LansleyCentre for Respiratory Health, School of Biomedical Sciences, University of Western Australia, Perth, AustraliaORCID Iconhttp://orcid.org/0000-0001-7157-8094View further author information
ORCID Icon,
Willem Joost LesterhuisNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaView further author information
,
Ian M. DickNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaORCID Iconhttp://orcid.org/0000-0003-1902-9033View further author information
ORCID Icon,
Anna K NowakNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Medicine, The University of Western Australia, Perth, AustraliaORCID Iconhttp://orcid.org/0000-0002-9317-9526View further author information
ORCID Icon,
Bruce W. RobinsonNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Medicine, The University of Western Australia, Perth, AustraliaView further author information
,
Richard A. LakeNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Medicine, The University of Western Australia, Perth, AustraliaView further author information
&
Scott A. FisherNational Centre for Asbestos Related Diseases (NCARD). Lv5 QQ Block (M503). QEII Medical Centre, The University of Western Australia, Perth, Australia;School of Biomedical Sciences, The University of Western Australia, Perth, AustraliaORCID Iconhttp://orcid.org/0000-0003-1551-5579View further author information
ORCID Icon show all
Article: e1494111 | Received 11 Apr 2018, Accepted 24 Jun 2018, Published online: 30 Jul 2018

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Anna K Nowak, Alison McDonnell & Alistair Cook. (2019) Immune checkpoint inhibition for the treatment of mesothelioma. Expert Opinion on Biological Therapy 19:7, pages 697-706.
Read now

Articles from other publishers (25)

Ram Kumar Sahu, Sakina Ruhi, Ashok Kumar Jeppu, Husni Ahmed Al-Goshae, Ayesha Syed, Sanjay Nagdev, Retno Widyowati, Wiwied Ekasari, Jiyauddin Khan, Bedanta Bhattacharjee, Manoj Goyal, Sankha Bhattacharya & Rajendra K. Jangde. (2023) Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies. Frontiers in Oncology 13.
Crossref
Esther Stern, Stefano Caruso, Clément Meiller, Inbal Mishalian, Theo Z. Hirsch, Quentin Bayard, Carmit T. Tadmor, Hanna Wald, Didier Jean & Ori Wald. (2023) Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics. Frontiers in Immunology 13.
Crossref
Chrysafis Andreou, Konstantinos Plakas, Naxhije Berisha, Mathieu Gigoux, Lauren E. Rosch, Rustin Mirsafavi, Anton Oseledchyk, Suchetan Pal, Dmitriy Zamarin, Taha Merghoub, Michael R. Detty & Moritz F. Kircher. (2022) Multiplexed molecular imaging with surface enhanced resonance Raman scattering nanoprobes reveals immunotherapy response in mice via multichannel image segmentation . Nanoscale Horizons 7:12, pages 1540-1552.
Crossref
Geraldine M. O’Connor & Emyr Y. Bakker. (2022) Patient-Level Omics Data Analysis Identifies Gene-Specific Survival Associations for a PD-1/PD-L1 Network in Pleural Mesothelioma. BioMedInformatics 2:4, pages 580-592.
Crossref
Rashi Yadav & William L. Redmond. (2022) Current Clinical Trial Landscape of OX40 Agonists. Current Oncology Reports 24:7, pages 951-960.
Crossref
Lukasz Kuryk, Giulia Rodella, Monika Staniszewska, Katarzyna Wanda Pancer, Magdalena Wieczorek, Stefano Salmaso, Paolo Caliceti & Mariangela Garofalo. (2022) Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects. Frontiers in Oncology 12.
Crossref
Nicola Principe, Wayne J. Aston, Danika E. Hope, Caitlin M. Tilsed, Scott A. Fisher, Louis Boon, Ian M. Dick, Wee Loong Chin, Alison M. McDonnell, Anna K. Nowak, Richard A. Lake, Jonathan Chee & Willem Joost Lesterhuis. (2022) Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations. Frontiers in Immunology 13.
Crossref
Bruce W.S. Robinson, Alec J. Redwood & Jenette Creaney. (2022) How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies. Frontiers in Pharmacology 13.
Crossref
Raffaella Massafra, Annamaria Catino, Pia Maria Soccorsa Perrotti, Pamela Pizzutilo, Annarita Fanizzi, Michele Montrone & Domenico Galetta. (2022) Informative Power Evaluation of Clinical Parameters to Predict Initial Therapeutic Response in Patients with Advanced Pleural Mesothelioma: A Machine Learning Approach. Journal of Clinical Medicine 11:6, pages 1659.
Crossref
Bo-Jin Chen, Jing-Wen Zhao, Da-Hong Zhang, Ai-Hong Zheng & Guo-Qing Wu. (2022) Immunotherapy of Cancer by Targeting Regulatory T cells. International Immunopharmacology 104, pages 108469.
Crossref
Vanessa S. Fear, Catherine A. Forbes, Samuel A. Neeve, Scott A. Fisher, Jonathan Chee, Jason Waithman, Shao Kang Ma, Richard Lake, Anna K. Nowak, Jenette Creaney, Matthew D. Brown, Christobel Saunders & Bruce W. S. Robinson. (2021) Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used. Cancer Immunology, Immunotherapy 70:11, pages 3249-3258.
Crossref
Fabio Nicolini & Massimiliano Mazza. 2021. Rare Diseases - Diagnostic and Therapeutic Odyssey. Rare Diseases - Diagnostic and Therapeutic Odyssey.
Meilin Chan, Licun Wu, Zhihong Yun, Trevor D. McKee, Michael Cabanero, Yidan Zhao, Mikihiro Kohno, Junichi Murakami & Marc de Perrot. (2021) Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma. Communications Biology 4:1.
Crossref
Rita Terenziani, Silvia Zoppi, Claudia Fumarola, Roberta Alfieri & Mara Bonelli. (2021) Immunotherapeutic Approaches in Malignant Pleural Mesothelioma. Cancers 13:11, pages 2793.
Crossref
Steven G. Gray. (2021) Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma. BMC Pulmonary Medicine 21:1.
Crossref
Elly Marcq, Jonas R. M. Van Audenaerde, Jorrit De Waele, Céline Merlin, Patrick Pauwels, Jan P. van Meerbeeck, Scott A. Fisher & Evelien L. J. Smits. (2021) The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3. Cancers 13:2, pages 282.
Crossref
Nicola Principe, Joel Kidman, Siting Goh, Caitlin M. Tilsed, Scott A. Fisher, Vanessa S. Fear, Catherine A. Forbes, Rachael M. Zemek, Abha Chopra, Mark Watson, Ian M. Dick, Louis Boon, Robert A. Holt, Richard A. Lake, Anna K. Nowak, Willem Joost Lesterhuis, Alison M. McDonnell & Jonathan Chee. (2020) Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy. Frontiers in Immunology 11.
Crossref
Bonnie S. Glisson, Rom S. Leidner, Robert L. Ferris, John Powderly, Naiyer A. Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James P. Ohr, Jennifer Burton, Yanan Zheng, Steven Eck, Matthew Gribbin, Katie Streicher, Danielle M. Townsley & Sandip Pravin Patel. (2020) Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors. Clinical Cancer Research 26:20, pages 5358-5367.
Crossref
Steven E Mutsaers, Fiona J Pixley, Cecilia M Prêle & Gerard F Hoyne. (2020) Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma. Current Opinion in Immunology 64, pages 88-109.
Crossref
Fabio Nicolini, Martine Bocchini, Davide Angeli, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò & Massimiliano Mazza. (2020) Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting. Cancers 12:4, pages 915.
Crossref
Trista K. Hinz & Lynn E. Heasley. (2020) Translating mesothelioma molecular genomics and dependencies into precision oncology-based therapies. Seminars in Cancer Biology 61, pages 11-22.
Crossref
Cecilia M Prêle & Gerard F Hoyne. (2020) Immunopathobiology of chronic lung disease. Clinical & Translational Immunology 9:8.
Crossref
V. S. Fear, C. A. Forbes, J. Chee, S. Ma, S. Neeve, L. Celliers, S. A. Fisher, I. Dick, J. Creaney & B. W. S. Robinson. (2019) Neo-antigen specific T cell responses indicate the presence of metastases before imaging. Scientific Reports 9:1.
Crossref
Vanessa S. Fear, Alistair M. Cook & Scott A. Fisher. 2019. Caring for Patients with Mesothelioma: Principles and Guidelines. Caring for Patients with Mesothelioma: Principles and Guidelines 203 227 .
Samuel C Neeve, Bruce WS Robinson & Vanessa S Fear. (2019) The role and therapeutic implications of T cells in cancer of the lung. Clinical & Translational Immunology 8:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.